trial · primary record
Rina-S
Non-small Cell Lung Cancer (NSCLC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 240 |
| Primary completion | 2028-11-22 |
| Primary endpoint | Objective Response Rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 as Assessed by Investigator |
| Registry ID | NCT07288177 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.589Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07288177
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Rina-S · compound